Zolpidem Administration and Risk of Hepatocellular Carcinoma: A Case-Control Study in Taiwan

Zolpidem Administration and Risk of Hepatocellular Carcinoma: A Case-Control Study in Taiwan

Background/Objectives: Previous studies showed that zolpidem use could be associated with increased cancer risk, but the role of zolpidem on hepatocellular carcinoma (HCC) risk remains undetermined. The study purpose was to examine the association between HCC risk and zolpidem use in Taiwan.Methods:...

Full description

Bibliographic Details
Main Authors: Shih-Wei Lai, Cheng-Li Lin, Kuan-Fu Liao
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-10-01
Series:Frontiers in Pharmacology
Subjects:
hepatocellular carcinoma
zolpidem
Taiwan
National Health Insurance Program
Online Access:http://journal.frontiersin.org/article/10.3389/fphar.2017.00767/full

Similar Items

Similar Items